Mary Mosher

Array ( [id] => 5495384 [patent_doc_number] => 20090263412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Non-Splicing Variants of gp350/220' [patent_app_type] => utility [patent_app_number] => 12/029182 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10317 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263412.pdf [firstpage_image] =>[orig_patent_app_number] => 12029182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6609055 [patent_doc_number] => 20100323428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'ATTENUATED MINUS-STRANDED RNA VIRUS' [patent_app_type] => utility [patent_app_number] => 12/526211 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20109 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323428.pdf [firstpage_image] =>[orig_patent_app_number] => 12526211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174462 [patent_doc_number] => 20110177114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'IMMEDIATE PROTECTION AGAINST PATHOGENS VIA MVA' [patent_app_type] => utility [patent_app_number] => 12/026612 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15915 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177114.pdf [firstpage_image] =>[orig_patent_app_number] => 12026612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302485 [patent_doc_number] => 20100068229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'RECOMBINANT ANTIGENS OF HUMAN CYTOMEGALOVIRUS (HCMV)' [patent_app_type] => utility [patent_app_number] => 12/525800 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12835 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068229.pdf [firstpage_image] =>[orig_patent_app_number] => 12525800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178497 [patent_doc_number] => 20110178269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Coronavirus S Peptides' [patent_app_type] => utility [patent_app_number] => 12/025195 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11295 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178269.pdf [firstpage_image] =>[orig_patent_app_number] => 12025195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392239 [patent_doc_number] => 20100303838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'VECTORS FOR MULTIPLE GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/599971 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19203 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303838.pdf [firstpage_image] =>[orig_patent_app_number] => 12599971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4556930 [patent_doc_number] => 07838277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Method for rapid screening of bacterial transformants and novel simian adenovirus proteins' [patent_app_type] => utility [patent_app_number] => 12/011377 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 19938 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838277.pdf [firstpage_image] =>[orig_patent_app_number] => 12011377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7489931 [patent_doc_number] => 08030029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Flu vaccines and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/011032 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 41 [patent_no_of_words] => 16610 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030029.pdf [firstpage_image] =>[orig_patent_app_number] => 12011032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244792 [patent_doc_number] => 08202717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus' [patent_app_type] => utility [patent_app_number] => 12/013236 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13939 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202717.pdf [firstpage_image] =>[orig_patent_app_number] => 12013236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527242 [patent_doc_number] => 20090197319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Virus-Like Particle Containing A Dengue Recombinant Replicon' [patent_app_type] => utility [patent_app_number] => 11/971343 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8837 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197319.pdf [firstpage_image] =>[orig_patent_app_number] => 11971343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697825 [patent_doc_number] => 20080220009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Rodent hepatitis B virus core proteins as vaccine platforms and methods of thereof' [patent_app_type] => utility [patent_app_number] => 12/008059 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 41976 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220009.pdf [firstpage_image] =>[orig_patent_app_number] => 12008059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4532649 [patent_doc_number] => 07888069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences' [patent_app_type] => utility [patent_app_number] => 11/962924 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 36 [patent_no_of_words] => 60944 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888069.pdf [firstpage_image] =>[orig_patent_app_number] => 11962924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8102959 [patent_doc_number] => 08153129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Antibodies against human cytimegalovirus (HCMV)' [patent_app_type] => utility [patent_app_number] => 12/519236 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14582 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153129.pdf [firstpage_image] =>[orig_patent_app_number] => 12519236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6380412 [patent_doc_number] => 20100316663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Subunit Vaccine for Aquaculture' [patent_app_type] => utility [patent_app_number] => 12/746409 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5108 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316663.pdf [firstpage_image] =>[orig_patent_app_number] => 12746409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625535 [patent_doc_number] => 20100034829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'LIQUID ANTI-RABIES ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/312967 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11170 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034829.pdf [firstpage_image] =>[orig_patent_app_number] => 12312967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220829 [patent_doc_number] => 20120135035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Induction of an immune response against dengue virus using the prime-boost approach' [patent_app_type] => utility [patent_app_number] => 11/982488 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3089 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11982488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82673 [patent_doc_number] => 07740852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Binding molecules capable of neutralizing rabies virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/978742 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 36168 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740852.pdf [firstpage_image] =>[orig_patent_app_number] => 11978742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8383973 [patent_doc_number] => RE043655 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2012-09-11 [patent_title] => 'Chromatographic method for high yield purification and viral inactivation of antibodies' [patent_app_type] => reissue [patent_app_number] => 11/873878 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6214 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11873878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483490 [patent_doc_number] => 20100008951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'FLU VACCINE ADMIXTURE OF MANNAN AND FLU ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/443048 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7103 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008951.pdf [firstpage_image] =>[orig_patent_app_number] => 12443048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7997045 [patent_doc_number] => 08080370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/311333 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9450 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080370.pdf [firstpage_image] =>[orig_patent_app_number] => 12311333 [rel_patent_id] =>[rel_patent_doc_number] =>)